Autori: Romiti Giulio Francesco
Naslov | Asymptomatic vs. symptomatic atrial fibrillation: Clinical outcomes in heart failure patients (Article) |
Autori | Boriani Giuseppe Bonini Niccolo Vitolo Marco Mei Davide Antonio Imberti Jacopo Francesco Gerra Luigi Romiti Giulio Francesco Corica Bernadette Proietti Marco Diemberger Igor Dan Gheorghe-Andrei Potpara Tatjana S Lip Gregory YH |
Info | EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2024), vol. 119 br. , str. 53-63 |
Projekat | European Union [899871] |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: Web of Science |
|
Naslov | Factors Associated with Progression of Atrial Fibrillation and Impact on All-Cause Mortality in a Cohort of European Patients (Article) |
Autori | Vitolo Marco Proietti Marco Imberti Jacopo F Bonini Niccolo Romiti Giulio Francesco Mei Davide A Malavasi Vincenzo Livio Diemberger Igor Fauchier Laurent Marin Francisco Nabauer Michael Potpara Tatjana S Dan Gheorghe-Andrei Lip Gregory YH Boriani Giuseppe |
Info | JOURNAL OF CLINICAL MEDICINE, (2023), vol. 12 br. 3, str. - |
Ispravka | Web of Science Članak Elečas Rang časopisa |
|
Naslov | Impact of ABC (Atrial Fibrillation Better Care) pathway adherence in high-risk subgroups with atrial fibrillation: A report from the ESC-EHRA EORP-AF long-term general registry (Article) |
Autori | Ding Wern Yew Proietti Marco Romiti Giulio Francesco Vitolo Marco Fawzy Ameenathul Mazaya Boriani Giuseppe Marin Francisco Blomstrom-Lundqvist Carina Potpara Tatjana S Fauchier Laurent Lip Gregory YH |
Info | EUROPEAN JOURNAL OF INTERNAL MEDICINE, (2023), vol. 107 br. , str. 60-65 |
Projekat | Abbott Vascular Int; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Servier; Edwards; Vifor; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi |
Ispravka | Web of Science Članak Elečas Rang časopisa Citati: |
|
Naslov | ABC adherence and impact of optimal medical therapy in heart failure patients with atrial fibrillation (Meeting Abstract) |
Autori | Bonini N Proetti M Romiti Giulio Francesco Vitolo Marrco Fawzy AM Ding WY Fauchier L Marin Francisco Nabauer Michael Potpara Tatjana S Dan GA Boriani G Lip GYH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 969-969 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Features of clinical complexity in european patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (Meeting Abstract) |
Autori | Proietti Marco Romiti Giulio Francesco Vitolo Marrco Bonini N Fawzy AM Ding WY Fauchier L Marin Francisco Nabauer Michael Potpara Tatjana S Dan GA Boriani G Lip GYH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 638-638 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor; PfizerAlliance |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Factors associated with progression of atrial fibrillation and impact on all-cause mortality: an ancillary analysis from the ESC-EHRA EURObservational Research Programme in Atrial Fibrillation General (Meeting Abstract) |
Autori | Vitolo Marrco Proietti M Bonini N Romiti Giulio Francesco Fauchier L Marin Francisco Nabauer Michael Potpara Tatjana S Dan GA Kalarus Z Tavazzi Luigi Maggioni AP Lane DA Lip GYH Boriani G |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 637-637 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Impact of ABC pathway adherence in high-risk patients with atrial fibrillation: an analysis from the ESC-EHRA EORP-AF long-term general registry (Meeting Abstract) |
Autori | Ding WY Proietti Marco Romiti Giulio Francesco Vitolo Marrco Fawzy AM Boriani Giuseppe Marin Francisco Blomstrom-Lundqvist Carina Potpara Tatjana S Fauchier L Lip Gregory YH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 563-563 |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Impact of the atrial fibrillation better care pathway in clinically complex patients with atrial fibrillation: a report from the ESC-EHRA EORP-AF General Long-Term Registry (Meeting Abstract) |
Autori | Romiti Giulio Francesco Proietti M Vitolo Marrco Bonini N Fawzy AM Ding WY Fauchier L Marin Francisco Nabauer Michael Dan GA Potpara Tatjana S Boriani G Lip GYH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 518-518 |
Projekat | EORP |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Anaemia and adverse outcomes in European patients with atrial fibrillation: a report from the ESC-EHRA EORP atrial fibrillation general long-term registry (Meeting Abstract) |
Autori | Boriani Giuseppe Vitolo Marrco Proietti Marco Malavasi Vincenzo Livio Bonini N Romiti Giulio Francesco Imberti Jacopo Francesco Fauchier Laurent Nabauer Michael Potpara Tatjana S Dan Gheorghe-Andrei Kalarus Zbigniew Maggioni Aldo Pietro Lane Deirdre A Lip Gregory YH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 497-497 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
Ispravka | Web of Science Elečas Rang časopisa |
|
Naslov | Heart failure and cardiovascular outcomes in european patients with atrial fibrillation (Meeting Abstract) |
Autori | Bonini N Proietti Marco Romiti Giulio Francesco Vitolo Marrco Fawzy AM Ding YD Fauchier L Marin Francisco Nabauer Michael Potpara Tatjana S Dan GA Boriani G Lip GYH |
Info | EUROPEAN HEART JOURNAL, (2022), vol. 43 br. , Suppl. 2, str. 2316-2316 |
Projekat | Abbott Vascular Int.; Amgen Cardiovascular; AstraZeneca; Bayer; Boehringer Ingelheim; Boston Scientific; Bristol Myers Squibb; Pfizer Alliance; Alliance Daiichi Sankyo Europe GmbH; Eli Lilly and Company; Edwards; Gedeon Richter Plc.; Menarini Int. Op.; MSD-Merck Co.; Novartis Pharma AG; ResMed; Sanofi; SERVIER; Vifor |
Ispravka | Web of Science Elečas Rang časopisa |
|